Pregnancy outcomes following unintentional exposure to a live-attenuated tetravalent dengue vaccine

Researchers from Takeda Pharmaceuticals (Switzerland) have published a case series of unplanned pregnancies occurring in phase 2 and 3 clinical trials of a tetravalent dengue vaccine. More information is available here.

Photo by National Institute of Allergy and Infectious Diseases on Unsplash